FASEB J. Mp Biomedicals
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.09-131847.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Buy
Right arrow All Versions of this Article:
fj.09-131847v1
23/11/3957    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Manni, I.
Right arrow Articles by Sacchi, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manni, I.
Right arrow Articles by Sacchi, A.
(The FASEB Journal. 2009;23:3957-3966.)
© 2009 FASEB

The microRNA miR-92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms

Isabella Manni*,1, Simona Artuso*,1, Silvia Careccia*, Maria Giulia Rizzo*, Renato Baserga{ddagger}, Giulia Piaggio*,{dagger},2 and Ada Sacchi*

* Experimental Oncology Department and

{dagger} Rome Oncogenomic Center (ROC), Istituto Regina Elena, Rome, Italy; and

{ddagger} Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA

2 Correspondence: Istituto Regina Elena, Via delle Messi D’Oro 156, 00158 Rome, Italy. E-mail: piaggio{at}ifo.it

MicroRNAs (miRs) are 21- to 23-nucleotide RNA molecules that regulate the stability or translational efficiency of target messenger RNAs of proteins involved in cell growth and apoptosis. miR-92 is part of the mir-17–92 cluster, which comprises members with an effect on cell proliferation. However, the role of miR-92 is unknown, and its targets have not been identified. Here, we describe a mechanism through which miR-92 contributes to regulate cell proliferation. Using a miR-92 synthetic double-strand oligonucleotide, we demonstrate that miR-92 increases 32D myeloid cell proliferation and 5-bromo-2-deoxyuridine (BrdU) incorporation and inhibits cell death. The effect is miR-92 specific since the miR-92 antagomir inhibits cell proliferation. Moreover, we show that miR-92 acts by modulating p63-isoform abundance through down-regulatation of endogenous {Delta}Np63β. Using luciferase reporters containing p63 3'UTR fragments with wild-type or mutant miR-92 complementary sites, we demonstrate that the wild-type 3'UTR is a direct target of miR-92. Finally, we observed that a miR-92-resistant {Delta}Np63β isoform (without 3'UTR) inhibits cell proliferation and parallels the effect of the antagomir. We conclude that one of the molecular mechanisms through which miR-92 increases cell proliferation is by negative regulation of an isoform of the cell-cycle regulator p63.—Manni, I., Artuso, S., Careccia, S., Rizzo, M. G., Baserga, R., Piaggio, G., Sacchi, A. The microRNA miR-92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms.


Key Words: 3'UTR • hematopoiesis • p53 family • small noncoding RNAs




This article has been cited by other articles:


Home page
Genes Dev.Home page
G. van Haaften and R. Agami
Tumorigenicity of the miR-17-92 cluster distilled
Genes & Dev., January 1, 2010; 24(1): 1 - 4.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The Federation of American Societies for Experimental Biology.